** Shares of AI biologics firm Absci Corp ABSI.O rise
30.6% to $4.01 premarket
** Co announces a strategic collaboration with Advanced
Micro Devices AMD.O , where the chipmaker will invest $20 mln
in co to power AI drug discovery
** The investment is structured as a private investment in
public equity or PIPE financing
** The partnership will provide AI solutions and also help
reduce infrastructure costs for ABSI
** ABSI will deploy AMD's AI chips to help in drug
discovery which "will enable us to further the development of
next-generation antibody therapeutics"- ABSI
** Absci previously struck a deal worth up to $247 mln with
drugmaker AstraZeneca AZN.L to design an antibody to fight
cancer
** Up to last close, ABSI had fallen 8.6% in the past 12
months
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))